Aims and Scope of Clinical Genitourinary Cancer
Clinical Genitourinary Cancer is a peer-reviewed medical journal published by Elsevier, and previously by CIG Media Group (Cancer Information Group). The journal publishes articles on detection, diagnosis, prevention, and treatment of genitourinary cancers. The main emphasis is on recent scientific developments in all areas related to genitourinary cancers. The journal was previously published as Clinical Prostate Cancer through September 2005. Less
Key Metrics
CiteScore 

5.5
Impact Factor 

< 5
SJR 

Q2Urology

SNIP 

0.97
Recommended pre-submission checks
Powered by 

Topics Covered on Clinical Genitourinary Cancer
Clinical Genitourinary Cancer Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | CIG MEDIA GROUP, LP |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2002 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Clinical Genitourinary Cancer ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Clinical Genitourinary Cancer
Corrigendum to "Urinary Exosomal miR-17-5p Accelerates Bladder Cancer Invasion by Repressing its Target Gene ARID4B and Regulating the Immune Microenvironment" [Clinical Genitourinary Cancer 22/2 (2024) 569-579.e1
- 4 Jun 2026
- Clinical genitourinary cancer
Beyond the Hazard Ratio: Time-Varying Treatment Effects in Genitourinary Cancer Trials.
- 3 Jun 2026
- Clinical genitourinary cancer
Radiation and Avelumab in Cisplatin-Ineligible Patients With Muscle-Invasive Bladder Cancer.
- 1 Jun 2026
- Clinical genitourinary cancer
Comparative Analysis of Risk Stratifications for Non-Muscle-Invasive Bladder Cancer According to the Classifications Provided by the National Comprehensive Cancer Network, European Association of Urology, and Japanese Urological Association Guidelines.
- 1 Jun 2026
- Clinical genitourinary cancer
Concomitant medications and survival outcomes in patients receiving avelumab maintenance for advanced urothelial carcinoma: sub analysis of Meet-URO 25 study.
- 1 Jun 2026
- Clinical genitourinary cancer
Renal Melanotic Xp11 Translocation PEComa (XTTP): A Retrospective Case Series Analysis.
- 1 Jun 2026
- Clinical genitourinary cancer
Corrigendum to "Urinary Exosomal miR-17-5p Accelerates Bladder Cancer Invasion by Repressing its Target Gene ARID4B and Regulating the Immune Microenvironment" [Clinical Genitourinary Cancer 22/2 (2024) 569-579.e1
- 4 Jun 2026
- Clinical genitourinary cancer
Beyond the Hazard Ratio: Time-Varying Treatment Effects in Genitourinary Cancer Trials.
- 3 Jun 2026
- Clinical genitourinary cancer
Radiation and Avelumab in Cisplatin-Ineligible Patients With Muscle-Invasive Bladder Cancer.
- 1 Jun 2026
- Clinical genitourinary cancer
Comparative Analysis of Risk Stratifications for Non-Muscle-Invasive Bladder Cancer According to the Classifications Provided by the National Comprehensive Cancer Network, European Association of Urology, and Japanese Urological Association Guidelines.
- 1 Jun 2026
- Clinical genitourinary cancer
Concomitant medications and survival outcomes in patients receiving avelumab maintenance for advanced urothelial carcinoma: sub analysis of Meet-URO 25 study.
- 1 Jun 2026
- Clinical genitourinary cancer
Renal Melanotic Xp11 Translocation PEComa (XTTP): A Retrospective Case Series Analysis.
- 1 Jun 2026
- Clinical genitourinary cancer